CoChat

Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C

Cardoso, Ana‐Carolina, Carvalho‐Filho, Roberto J., Stern, Christiane, Dipumpo, Alexandrine, Giuily, Nathalie, Ripault, Marie‐Pierre, Asselah, Tarik, Boyer, Nathalie, Lada, Olivier, Castelnau, Corinne, Martinot‐Peignoux, Michelle, Valla, Dominique‐Charles, Bedossa, Pierre, Marcellin, Patrick · 2012 · Liver International
Cited by 149

The DOI matches its Crossref record.

Abstract

Background/Aims: Accuracy of transient elastography (TE) in hepatitis B virus (HBV) infection has not been well established. We aimed to compare the performances of TE for the assessment of liver fibrosis in patients with chronic HBV or hepatitis C virus (HCV) infection. A secondary analysis was performed to assess whether or not alanine aminotransferase (ALT) levels would impact on the accuracy of TE. Methods: This cross‐sectional study, carried out in a single centre, included treatment‐naïve patients with compensated chronic HBV or HCV infection, consecutively admitted between 2006 and 2008 for a liver biopsy and TE measurement on the same day. Results: A total of 202 HBV patients and 363 HCV subjects were evaluated. Overall diagnostic accuracy of TE in the HBV group was comparable to that observed in HCV patients [area under the receiver‐operating characteristics (AUROC s) 0.867 ± 0.026 vs. 0.868 ± 0.019 for predicting F ≥ 2, P = 0.975; 0.902 ± 0.029 vs. 0.894 ± 0.020 for F ≥ 3, P = 0.820; and 0.935 ± 0.024 vs. 0.947 ± 0.027 for F4, P = 0.740 respectively]. TE exhibited comparable accuracies, sensitivities, specificities, predictive values and likelihood ratios in HBV and HCV groups. AUROC analysis showed no influence of ALT levels on the performance of TE in HBV individuals. ALT‐specific cut‐off values did not exhibit significantly higher diagnostic performances for predicting fibrosis in HBV patients with elevated ALT. Conclusions: In HBV patients, TE measurement accurately predicts the absence or presence of significant fibrosis, advanced fibrosis or cirrhosis and shows similar performances as compared to HCV patients. The use of TE cut‐off values adjusted to ALT level did not improve performances for estimating liver fibrosis in HBV patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1478-3231.2011.02660.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 149

Metadata

Authors
Cardoso, A., Carvalho‐Filho, R. J., Stern, C., Dipumpo, A., Giuily, N., Ripault, M., Asselah, T., Boyer, N., Lada, O., Castelnau, C., Martinot‐Peignoux, M., Valla, D., Bedossa, P., & Marcellin, P.
Venue
Liver International
Publisher
Wiley
Published
2011-11-22
Volume
32
Issue
4
Pages
612-621
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W2007896489
Cited by
149
References
0
FWCI
9.08
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. https://app.cochat.ai/papers/10.1111/j.1478-3231.2011.02660.x
The paper
Cardoso, A., Carvalho‐Filho, R. J., Stern, C., Dipumpo, A., Giuily, N., Ripault, M., Asselah, T., Boyer, N., Lada, O., Castelnau, C., Martinot‐Peignoux, M., Valla, D., Bedossa, P., & Marcellin, P. (2012). Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver International. https://doi.org/10.1111/j.1478-3231.2011.02660.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.